PAR
Paradigm Biopharmaceuticals Limited..
Pharmaceuticals, Biotechnology & Life Sciences
Paradigm Biopharmaceuticals is a late-stage drug development company with the mission to develop and commercialise pentosan polysulfate sodium for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, ageing, dege
Shorted
short percentage0.33%
reported shorts1.4M
shares on issue433.683M
About
website
industry
address
Key Metrics
market cap
$132.27Meps$-0.06
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Short Position Trends
Track bearish sentiment and short interest over time
Historical Price Data
View stock price movements, volume, and trading patterns